Cynata Therapeutics (CYP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CYP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?August 30, 2025 | finance.yahoo.comCynata Therapeutics Ltd (CYP) - Investing.com UKAugust 23, 2025 | uk.investing.comDiabetic Foot Ulcers Market to Experience Notable Growth by 2034, DelveInsight Predicts | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma ...August 22, 2025 | theglobeandmail.comCynata Therapeutics Issues Shares to Strengthen Financial PositionAugust 22, 2025 | msn.comCynata Therapeutics Announces Quotation of New SecuritiesAugust 22, 2025 | msn.comCynata Therapeutics to Present at Bioshares Biotech Summit, Highlighting Key DevelopmentsAugust 6, 2025 | tipranks.comCynata Therapeutics Hosts Investor Webinar to Discuss Progress and Future PlansAugust 4, 2025 | tipranks.comCynata Therapeutics Ltd Stock Price History - Investing.comJuly 5, 2025 | investing.comCynata Therapeutics Ltd (51S.SG) - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comCynata Therapeutics Launches InvestorHub to Enhance EngagementMay 21, 2025 | msn.comGraft Versus Host Disease Market is Projected for Substantial Expansion from USD 1.3 Billion in 2023| DelveInsightMarch 13, 2025 | theglobeandmail.comThe ASX players bringing new hope to IPF sufferersMarch 13, 2025 | msn.comCynata's stem cell tech verified in peer-reviewed studyFebruary 4, 2025 | msn.comHealth Check: Pro Medicus founders cashed up for the festive seasonDecember 5, 2024 | msn.comHealth Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slumpDecember 5, 2024 | msn.comCynata Therapeutics Marks Strong Progress and Share RecoveryNovember 20, 2024 | markets.businessinsider.comCynata Therapeutics Unveils New Investor PresentationNovember 12, 2024 | markets.businessinsider.comCynata Therapeutics Ltd (51S.SG)July 25, 2024 | nz.finance.yahoo.comHere's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn SituationJuly 19, 2024 | finance.yahoo.comFurther CYP-001 GvHD Clinical Data Published in Nature MedicineMay 22, 2024 | finance.yahoo.comCynata Therapeutics Ltd (CYP)April 13, 2024 | investing.comCynata Therapeutics: Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical TrialApril 8, 2024 | finanznachrichten.dePatient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical TrialApril 7, 2024 | finance.yahoo.comCynata Therapeutics: First Patient Treated in Phase 2 GvHD TrialMarch 5, 2024 | finanznachrichten.deEncouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical TrialFebruary 26, 2024 | finance.yahoo.comCompanies Like Cynata Therapeutics (ASX:CYP) Could Be Quite RiskyFebruary 8, 2024 | finance.yahoo.comCynata Therapeutics Ltd CYPJanuary 6, 2024 | morningstar.comMWe're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash BurnFebruary 5, 2023 | finance.yahoo.comStem Cells Market Size to be Worth $31.6 Billion by 2030 at CAGR of 11.4%: Grand View Research, Inc.October 27, 2022 | yahoo.comHere's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn SituationJune 23, 2022 | finance.yahoo.comAK-47 and Student ‘Hit List’ Found Destined for Another Texas School, District SaysMay 27, 2022 | yahoo.comASX Health Stocks: Cynata signs deal with FujiFilm, set to produce MSC stem cells on a mass scaleDecember 28, 2021 | msn.comCynata Therapeutics Limited (CYP.AX)November 9, 2021 | uk.finance.yahoo.comInvestors in Cynata Therapeutics (ASX:CYP) have unfortunately lost 47% over the last three yearsOctober 16, 2021 | finance.yahoo.comCynata Therapeutics Ltd.July 23, 2021 | barrons.com Get Cynata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYP Media Mentions By Week CYP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYP News Sentiment▼0.000.93▲Average Medical News Sentiment CYP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYP Articles This Week▼00▲CYP Articles Average Week Get the Latest News and Ratings for CYP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cynata Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FARN News Today AVCT News Today TH News Today NGENF News Today CYBN News Today 4BB News Today BVXP News Today HBP News Today SCLP News Today MDNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CYP) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cynata Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cynata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYP Stock Alerts